Sandra Jerrold-Jones obtained a BA from Rutgers College in biochemistry and went on to earn a PhD in immunology from the University of Pennsylvania. After completion of her degree, Saouaf went to work in the cell signaling laboratory of Bristol-Myers Squibb where she completed her post doctorate fellowship. She then worked briefly at GlaxoSmithKline before returning to the University of Pennsylvania. Saouaf left the university and began a consulting business with pharmaceutical and biotechnical companies, hoping to help speed the process of discoveries for drugs to treat autoimmune disease. In 2012, together with University of Pennsylvania colleagues, she "discovered a possible treatment approach...through oral drugs" and founded Atlantic Bio Sci, LLC. In 2013, she won a Fellowship from the Alliance of Women Entrepreneurs.
Selected works
Weiner, D B; Williams, W V; Siegel, R M; Jerrold-Jones, S; etal. (January 1989). "Molecular characterization of suppressor T cells". Transplantation Proceedings. 20 (6): 1151–1153. PMID2974197.
Siegel, Richard M; Katsumata, Makoto; Komori, Shinji; Jerrold-Jones, Sandra; etal. (December 1990). "Mechanisms of Autoimmunity in the Context of T-Cell Tolerance: Insights from Natural and Transgenic Animal Model Systems". Immunological Reviews. 118 (1): 165–192. doi:10.1111/j.1600-065X.1990.tb00816.x. PMID2150401. S2CID24544491.
Saouaf, Sandra J; Brennan, Patrick J; Shen, Yuan; Greene, Mark I. (December 2003). "Mechanisms of peripheral immune tolerance: Conversion of the immune to the unresponsive phenotype". Immunologic Research. 28 (3): 193–199. doi:10.1385/ir:28:3:193. PMID14713714. S2CID27480991.